5 research outputs found

    Characterization on Performance, Morphologies and Molecular Properties of Dual-Surfactants Based Polyvinylidene Fluoride Ultrafiltration Membranes

    Get PDF
    This paper addressed the pioneering work on the effects of dual surfactants component on the performance, morphologies and molecular properties of polyvinylidene fluoride/polyether glycol (PVDF/PEG 200) ultrafiltration (UF) membranes. The PVDF surfactant membranes were prepared via dry/wet via phase inversion technique with the addition of sodium dodecyl sulfate (SDS)/Tween 80 and Triton X-100/Tween 80 into polymer solution. Experimental data revealed that the dual surfactants improved the membrane performance up to 120.84 L/m2 Ã— h and 82 % of permeate flux and rejection of bovine serum albumin, respectively. In addition, 2 wt% of dual surfactants alsofound to induce the growth of fine finger-like and macro-voids cavities inside the membranes while the FTIR spectra proved that the existence of dual surfactants in PVDF membranes produced better molecular alignment which contributed significantly towards better flux and good rejection. In conclusion, the used of dual surfactants in the PVDF ultrafiltration membranes improved the performance-properties of the membranes and extending the possibly versatile for the membrane to be used for more applications

    Development of Asymmetric Low Pressure Reverse Osmosis-Surfactants Membrane: Effect of Surfactant Types and Concentration

    Get PDF
    The effect of surfactants that are cationic (Cetyl trimethylammonium bromide (CTAB)), anionic (Sodium Dodecyl Sulphate (SDS)) and non-ionic (Triton X-100) on performance, morphologies and molecular orientation of Polysulfone (PSF) low pressure reverse osmosis (LPRO) membrane were addressed. The experimental data showed that the increasing of 0.5 wt% in surfactant concentration produced higher pure water permeation (PWP) and flux. At 2.5 wt% of SDS, the LPRO membranes achieved the highest PWP of about  64.42 L/m2 Ã— h while 3.0 wt% of CTAB demonstrated the highest flux of 55.28 L/m2 Ã— h. Analysis from morphological results foundthat the optimal performance at 89.6 % rejection was produced by the membrane with 2 wt% SDS which is a good promoter for the fine morphological structures of the membrane, thus producing fine spectrum of molecular orientation factor

    Investigating Genetic and Other Determinants of First-Onset Myocardial Infarction in Malaysia:Protocol for the Malaysian Acute Vascular Events Risk Study

    No full text
    BACKGROUND: Although the burden of premature myocardial infarction (MI) is high in Malaysia, direct evidence on the determinants of MI in this multi-ethnic population remains sparse. OBJECTIVE: The Malaysian Acute Vascular Events Risk (MAVERIK) study is a retrospective case-control study established to investigate the genomic, lipid-related, and other determinants of acute MI in Malaysia. In this paper, we report the study protocol and early results. METHODS: By June 2019, we had enrolled approximately 2500 patients with their first MI and 2500 controls without cardiovascular disease, who were frequency-matched by age, sex, and ethnicity, from 17 hospitals in Malaysia. For each participant, serum and whole blood have been collected and stored. Clinical, demographic, and behavioral information has been obtained using a 200-item questionnaire. RESULTS: Tobacco consumption, a history of diabetes, hypertension, markers of visceral adiposity, indicators of lower socioeconomic status, and a family history of coronary disease were more prevalent in cases than in controls. Adjusted (age and sex) logistic regression models for traditional risk factors indicated that current smoking (odds ratio [OR] 4.11, 95% CI 3.56-4.75; P30 kg/m(2); OR 1.19, 95% CI 1.05-1.34; P=.009) were associated with MI in age- and sex-adjusted models. CONCLUSIONS: The MAVERIK study can serve as a useful platform to investigate genetic and other risk factors for MI in an understudied Southeast Asian population. It should help to hasten the discovery of disease-causing pathways and inform regionally appropriate strategies that optimize public health action. INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID): RR1-10.2196/3188
    corecore